These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17339236)

  • 21. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization.
    Hemingway H; Crook AM; Feder G; Banerjee S; Dawson JR; Magee P; Philpott S; Sanders J; Wood A; Timmis AD
    N Engl J Med; 2001 Mar; 344(9):645-54. PubMed ID: 11228280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial.
    Sculpher M; Manca A; Abbott J; Fountain J; Mason S; Garry R
    BMJ; 2004 Jan; 328(7432):134. PubMed ID: 14711748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip.
    de Verteuil R; Imamura M; Zhu S; Glazener C; Fraser C; Munro N; Hutchison J; Grant A; Coyle D; Coyle K; Vale L
    Health Technol Assess; 2008 Jun; 12(26):iii-iv, ix-223. PubMed ID: 18513467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary artery stents: a rapid systematic review and economic evaluation.
    Hill R; Bagust A; Bakhai A; Dickson R; Dündar Y; Haycox A; Mujica Mota R; Reaney A; Roberts D; Williamson P; Walley T
    Health Technol Assess; 2004 Sep; 8(35):iii-iv, 1-242. PubMed ID: 15361315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris.
    van den Brand M; van Halem C; van den Brink F; de Feyter P; Serruys P; Suryapranata H; Meeter K; Bos E; van Dalen FJ
    Eur Heart J; 1990 Aug; 11(8):765-71. PubMed ID: 2118854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989.
    Wong JB; Sonnenberg FA; Salem DN; Pauker SG
    Ann Intern Med; 1990 Dec; 113(11):852-71. PubMed ID: 2146912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
    Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
    Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of the impact of nicorandil in angina (IONA) trial.
    Walker A; McMurray J; Stewart S; Berger W; McMahon AD; Dargie H; Fox K; Hillis S; Henderson NJ; Ford I
    Heart; 2006 May; 92(5):619-24. PubMed ID: 16614274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.
    Thomas KJ; MacPherson H; Ratcliffe J; Thorpe L; Brazier J; Campbell M; Fitter M; Roman M; Walters S; Nicholl JP
    Health Technol Assess; 2005 Aug; 9(32):iii-iv, ix-x, 1-109. PubMed ID: 16095547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions.
    Fearon WF; Yeung AC; Lee DP; Yock PG; Heidenreich PA
    Am Heart J; 2003 May; 145(5):882-7. PubMed ID: 12766748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial.
    Rivero-Arias O; Campbell H; Gray A; Fairbank J; Frost H; Wilson-MacDonald J
    BMJ; 2005 May; 330(7502):1239. PubMed ID: 15911536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction.
    Mowatt G; Vale L; Brazzelli M; Hernandez R; Murray A; Scott N; Fraser C; McKenzie L; Gemmell H; Hillis G; Metcalfe M
    Health Technol Assess; 2004 Jul; 8(30):iii-iv, 1-207. PubMed ID: 15248938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors easily obtained at presentation predict resource utilization in unstable angina.
    Calvin JE; Klein LW; VandenBerg BJ; Meyer P; Ramirez-Morgen LM; Parrillo JE
    Am Heart J; 1998 Sep; 136(3):373-81. PubMed ID: 9736126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is medical treatment for angina the most cost-effective option?
    Cleland JG; Walker A
    Eur Heart J; 1997 May; 18 Suppl B():B35-42. PubMed ID: 9152668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
    Cohen DJ; Lavelle TA; Van Hout B; Li H; Lei Y; Robertus K; Pinto D; Magnuson EA; Mcgarry TF; Lucas SK; Horwitz PA; Henry CA; Serruys PW; Mohr FW; Kappetein AP
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):198-209. PubMed ID: 21542113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.